Otro
Estudo comparativo das complicações terapêuticas no Lúpus Eritematoso Sistêmico e nas glomerulopatias idiopáticas.
Registro en:
Revista da Associacao Medica Brasileira (1992), v. 47, n. 4, p. 296-301, 2001.
0104-4230
10.1590/S0104-42302001000400031
S0104-42302001000400031
2-s2.0-0035495938.pdf
2-s2.0-0035495938
Autor
Balbi, André Luis
Barbosa, R. A.
Lima, M. C.
Almeida, D. B.
Resumen
PURPOSE: To evaluate the therapeutic complications due to the use of immunosupressors in patients with nephropathy. METHODS: 76 patients who had used steroids and cyclophosphamide were retrospectively studied. The cases were divided into three groups: G1= 15 patients with Systemic Lupus Erythematosus without renal lesion; G2= 33 patients with lupus nephritis and G3= 28 patients with nephrotic syndrome owing to idiopathic glomerulopathy. RESULTS: There were no differences related to time of follow up (G1= 42.4 +/- 51, G2= 52.3 +/- 51, G3= 41.8 +/- 47.8 months), total used dosage of steroids (G1= 20, G2= 28, G3= 16 grams) and time of drug use (G1= 20, G2= 26, G3= 14.5 months). About cyclophosphamide use, there was no difference in the percentage of patients who used it (13% in G1, 51% in G2, 28% in G3), but the patients from G1 received lower total dosage than those from G2 (p<0.05). Cushingoid appearance, epigastric distress, psychiatric disorders, diabetes mellitus and ocular alterations occurred in all the three groups, with no statistically significant differences. The infections complications, those considered more severe clinically, were more frequent in G2 (G1= 6%, G2= 15%, G3= 0% - p<0.05), the same occurring with the deaths (7% in G1, 30% in G2, 0% in G3 - p<0.05). CONCLUSION: In patients with lupus nephritis there were more infections complications owing to prolonged immunosuppresion what may indicate a severity marker of this type of lesion.
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Alteraciones funcionales del timo en el modelo murino NZBWF1 de lupus eritematoso sistémico
Bono-Merino, María Rosa; Sauma-Mahaluf, Daniela Macarena; UNIVERSIDAD DE CHILE (2018)El lupus eritematoso sistémico (LES) es una enfermedad autoinmune caracterizada por la activación de linfocitos T y B autorreactivos, producción de autoanticuerpos y deposición de complejos inmunes en varios órganos. ... -
Alteraciones funcionales del timo en el modelo murino NZBWF1 de lupus eritematoso sistémico
Hidalgo-Fadic, Yessia -
Assistência de enfermagem a paciente com lupus eritematoso sistêmico utilizando a CIPE
Gouveia Dias Bittencourt, Greicy Kelly; Fernandes Beserra, Patrícia Josefa; Lima da Nobrega, Maria Miriam